Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2016 3
2017 2
2018 1
2019 2
2020 8
2021 9
2022 12
2023 13
2024 18
2025 13
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean darraji a[au] (31 results)?
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension.
Laffin LJ, Kopjar B, Melgaard C, Wolski K, Ibbitson J, Bhikam S, Weir MR, Ofili EO, Mehra R, Luther JM, Cohen DL, Sarraju A, Wilkinson MJ, Flack JM, Rodman D, Nissen SE; Advance-HTN Investigators. Laffin LJ, et al. Among authors: sarraju a. N Engl J Med. 2025 May 8;392(18):1813-1823. doi: 10.1056/NEJMoa2501440. Epub 2025 Apr 23. N Engl J Med. 2025. PMID: 40267417 Clinical Trial.
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3.
Laffin LJ, Nicholls SJ, Scott RS, Clifton PM, Baker J, Sarraju A, Singh S, Wang Q, Wolski K, Xu H, Nielsen J, Patel N, Duran JM, Nissen SE. Laffin LJ, et al. Among authors: sarraju a. N Engl J Med. 2025 Nov 27;393(21):2119-2130. doi: 10.1056/NEJMoa2511778. Epub 2025 Nov 8. N Engl J Med. 2025. PMID: 41211945 Clinical Trial.
2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
Palaniappan LP, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Bansal N, Currie ME, Earlie RS, Fan W, Fetterman JL, Barone Gibbs B, Heard DG, Hiremath S, Hong H, Hyacinth HI, Ibeh C, Jiang T, Johansen MC, Kazi DS, Ko D, Kwan TW, Leppert MH, Li Y, Magnani JW, Martin KA, Martin SS, Michos ED, Mussolino ME, Ogungbe O, Parikh NI, Perez MV, Perman SM, Sarraju A, Shah NS, Springer MV, St-Onge MP, Thacker EL, Tierney S, Urbut SM, Van Spall HGC, Voeks JH, Whelton SP, Wong SS, Zhao J, Khan SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee. Palaniappan LP, et al. Among authors: sarraju a. Circulation. 2026 Mar 3;153(9):e275-e906. doi: 10.1161/CIR.0000000000001412. Epub 2026 Jan 21. Circulation. 2026. PMID: 41562125 Free article. Review.
Obicetrapib-the Rebirth of CETP Inhibitors?
Chang B, Laffin LJ, Sarraju A, Nissen SE. Chang B, et al. Among authors: sarraju a. Curr Atheroscler Rep. 2024 Oct;26(10):603-608. doi: 10.1007/s11883-024-01231-5. Epub 2024 Aug 16. Curr Atheroscler Rep. 2024. PMID: 39150671 Free PMC article. Review.
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial.
Sarraju A, Brennan D, Hayden K, Stronczek A, Goldberg AC, Michos ED, McGuire DK, Mason D, Tercek G, Nicholls SJ, Kling D, Neild AL, Kastelein J, Davidson M, Ditmarsch M, Nissen SE. Sarraju A, et al. Lancet. 2025 May 17;405(10491):1757-1768. doi: 10.1016/S0140-6736(25)00721-4. Epub 2025 May 7. Lancet. 2025. PMID: 40347969 Clinical Trial.
Let Them Be Sick.
Sarraju A. Sarraju A. JAMA. 2022 Feb 22;327(8):721-722. doi: 10.1001/jama.2022.0796. JAMA. 2022. PMID: 35191921 No abstract available.
Novel Therapies for Familial Hypercholesterolemia.
Parizo J, Sarraju A, Knowles JW. Parizo J, et al. Among authors: sarraju a. Curr Treat Options Cardiovasc Med. 2016 Nov;18(11):64. doi: 10.1007/s11936-016-0486-2. Curr Treat Options Cardiovasc Med. 2016. PMID: 27620638 Review.
80 results